Yes, it ran fast from 10c to 50c, yes, valued on PE ratio alone it is overvalued.
But based on how the drugs compare to current treatments and what those sell for IMU's sp should be in the $ range.
PD1 Ph1 cohort 2 update with a short hint at efficacy was unusual compared to previous Her-Vaxx updates. Just underlined how powerful PD1-Vaxx is. Any day a cohort 3 update with an efficacy update can send it back to 50c.
Those who ridicule Her-Vaxx, it was an independent committee that recommended the shortening of pH 2 due to the incredible results shown.
Follow the science and the scientists, they are the ones in the know. Not the HC posters. What ever the charts may suggest, the sp will adjust to the achievements. And based on that the current level is at a fraction of what is to come. Looking forward to similar comments when sp falls from $5 to $3 after another hard run.
GLTA
IMUGENE CHART. TA only, page-2495
-
- There are more pages in this discussion • 30,996 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |